SantarpiaJL, RiveraDN, HerreraVL, et al.Aerosol and surface contamination of SARS-CoV-2 observed in quarantine and isolation care. Sci Rep, 2020; 10(1):12732; doi: 10.1038/s41598-020-69286-3
van DoremalenN, BushmakerT, MorrisDH, et al.Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med, 2020; 382(16):1564–1567; doi: 10.1056/NEJMc2004973
4.
SomsenGA, van RijnC, KooijS, BemRA, BonnD. Small droplet aerosols in poorly ventilated spaces and SARS-CoV-2 transmission. Lancet Respir Med, 2020; 8(7):658–659; doi: 10.1016/S2213-2600(20)30245-9
5.
LiJ, JingG, FinkJB, et al.Airborne particulate concentrations during and after pulmonary function testing. Chest, 2021; 159(4):1570–1574; doi: 10.1016/j.chest.2020.10.064
6.
GreeningNJ, LarssonP, LjungströmE, SiddiquiS, OlinAC. Small droplet emission in exhaled breath during different breathing manoeuvres: Implications for clinical lung function testing during COVID-19. Allergy, 2021; 76(3):915–917; doi: 10.1111/all.14596
7.
HelgesonSA, LimKG, LeeAS, NivenAS, PatelNM. Aerosol generation during spirometry. Ann Am Thorac Soc, 2020; 17(12):1637–1639; doi: 10.1513/AnnalsATS.202005-569RL
8.
SheikhS, HamiltonFW, NavaGW, et al.AERATOR Group. Are aerosols generated during lung function testing in patients and healthy volunteers? Results from the AERATOR study. Thorax, 2022; 77(3):292–294; doi: 10.1136/thoraxjnl-2021-217671
9.
GrahamBL, SteenbruggenI, MillerMR, et al.Standardization of spirometry 2019 update. an official American Thoracic Society and European Respiratory Society technical statement. Am J Respir Crit Care Med, 2019; 200(8):e70–e88; doi: 10.1164/rccm.201908-1590ST
10.
BakeB, LarssonP, LjungkvistG, LjungströmE, OlinAC. Exhaled particles and small airways. Respir Res, 2019; 20(1):8; doi: 10.1186/s12931-019-0970-9
11.
FennellyKP. Particle sizes of infectious aerosols: implications for infection control. Lancet Respir Med, 2020; 8(9):914–924; doi: 10.1016/S2213-2600(20)30323-4
12.
SubatYW, HainyME, TorgerudKD, et al.Aerosol generation and mitigation during methacholine bronchoprovocation testing: infection control implications in the era of COVID-19. Respir Care, 2021; 66(12):1858–1865; doi: 10.4187/respcare.09236
13.
MattL, MirzoyanM, TaylorHC, ButlerR, GopalakrishnaKV. Bacteriologic assessment of reused metered dose inhalers: an analysis of the safety of the “Common Canister Protocol.” Infectious Diseases in Clinical Practice, 2011; 19(4):265–267; doi: 10.1097/IPC.0b013e31820dc5d8
14.
LarsonT, GudavalliR, PraterD, SuttonS. Critical analysis of common canister programs: a review of cross-functional considerations and health system economics. Curr Med Res Opin, 2015; 31(4):853–860; doi: 10.1185/03007995.2015.1016604
